Canada Life
RUBY

Canada Life’s Rubius Therapeutics, Inc RUBY Stock Holding History

Canada Life’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,259
Closed -$13K – 2482
2022
Q1 		$13K Hold
2,259
– – ﹤0.01% 2410
2021
Q4 		$22K Hold
2,259
– – ﹤0.01% 2368
2021
Q3 		$41K Hold
2,259
– – ﹤0.01% 2285
2021
Q2 		$55K Hold
2,259
– – ﹤0.01% 2245
2021
Q1 		$59K Hold
2,259
– – ﹤0.01% 2247
2020
Q4 		$17K Hold
2,259
– – ﹤0.01% 2564
2020
Q3 		$11K Hold
2,259
– – ﹤0.01% 2521
2020
Q2 		$13K Hold
2,259
– – ﹤0.01% 2553
2020
Q1 		$10K Hold
2,259
– – ﹤0.01% 2515
2019
Q4 		$21K Buy
+2,259
New +$21.9K ﹤0.01% 2491
2019
Q3 		– Sell
-4,257
Closed -$67K – 2474
2019
Q2 		$67K Buy
+4,257
New +$68.7K ﹤0.01% 2358

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Canada Life's RUBY Position: Q2 2022 in Review

Canada Life sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2022, closing a stake of 2,259 shares — an estimated $13K sold.

Canada Life first reported a position in RUBY in Q2 2019 and held it in 11 quarters. The position peaked at $67K in Q2 2019. 72 funds tracked by Wall St. Rank hold RUBY as of Q2 2022.

  • Canada Life reported no remaining Rubius Therapeutics, Inc position as of Q2 2022 after selling out during the quarter.
  • Canada Life sold 2,259 Rubius Therapeutics, Inc shares in Q2 2022, an estimated $13K.
  • Canada Life first reported a position in Rubius Therapeutics, Inc in Q2 2019 and held it in 11 quarters.
  • Canada Life's Rubius Therapeutics, Inc position peaked at $67K in Q2 2019.
  • 72 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.